BGB-16673
BGB-16673-107
Phase 1 small_molecule active
Quick answer
BGB-16673 for Chronic Spontaneous Urticaria is a Phase 1 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Chronic Spontaneous Urticaria
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active